British Journal of Pharmacology,
Journal Year:
2014,
Volume and Issue:
172(9), P. 2167 - 2178
Published: Dec. 24, 2014
Autophagy
is
a
cellular
catabolic
process
responsible
for
the
destruction
of
long-lived
proteins
and
organelles
via
lysosome-dependent
pathway.
This
great
importance
in
maintaining
homeostasis,
deregulated
autophagy
has
been
implicated
pathogenesis
wide
range
diseases.
A
growing
body
evidence
suggests
that
can
be
activated
vascular
disorders
such
as
atherosclerosis.
occurs
under
basal
conditions
mediates
homeostatic
functions
cells
but
setting
pathological
states
up-regulated
exert
both
protective
detrimental
functions.
Therefore,
precise
role
its
relationship
with
progression
disease
need
to
clarified.
review
highlights
recent
findings
regarding
activity
potential
contribution
focus
on
atherogenesis.
Finally,
whether
manipulation
represents
new
therapeutic
approach
treat
or
prevent
diseases
also
discussed.
British Journal of Pharmacology,
Journal Year:
2014,
Volume and Issue:
172(8), P. 1996 - 2009
Published: Oct. 9, 2014
Cardiomyocyte
cell
death
occurring
during
myocardial
reperfusion
(reperfusion
injury)
contributes
to
final
infarct
size
after
transient
coronary
occlusion.
Different
interrelated
mechanisms
of
injury
have
been
identified,
including
alterations
in
cytosolic
Ca
2+
handling,
sarcoplasmic
reticulum‐mediated
oscillations
and
hypercontracture,
proteolysis
secondary
calpain
activation
mitochondrial
permeability
transition.
All
these
occur
the
initial
minutes
are
inhibited
by
intracellular
acidosis.
The
cGMP/PKG
pathway
modulates
rate
recovery
pH,
but
has
also
direct
effect
on
is
depressed
cardiomyocytes
ischaemia/reperfusion
preserved
ischaemic
postconditioning,
which
importantly
postconditioning
protection.
present
article
reviews
consequences
pathway,
different
pharmacological
strategies
aimed
stimulate
it
evidence,
limitations
promise
translation
clinical
practice.
Overall,
preclinical
evidence
suggests
that
modulation
may
be
a
therapeutic
target
context
infarction.
Linked
Articles
This
part
themed
section
Conditioning
Heart
–
Pathways
Translation.
To
view
other
articles
this
visit
http://dx.doi.org/10.1111/bph.2015.172.issue‐8
British Journal of Pharmacology,
Journal Year:
2015,
Volume and Issue:
172(13), P. 3412 - 3425
Published: March 13, 2015
Benzofurans
are
newly
used
psychoactive
substances,
but
their
pharmacology
is
unknown.
The
aim
of
the
present
study
was
to
pharmacologically
characterize
benzofurans
in
vitro.
British Journal of Pharmacology,
Journal Year:
2014,
Volume and Issue:
172(8), P. 1913 - 1932
Published: Sept. 10, 2014
Ischaemic
pre-
and
postconditioning
are
potent
cardioprotective
interventions
that
spare
ischaemic
myocardium
decrease
infarct
size
after
periods
of
myocardial
ischaemia/reperfusion.
They
dependent
on
complex
signalling
pathways
involving
ligands
released
from
myocardium,
G-protein-linked
receptors,
membrane
growth
factor
phospholipids,
kinases,
NO,
PKC
PKG,
mitochondrial
ATP-sensitive
potassium
channels,
reactive
oxygen
species,
TNF-α
sphingosine-1-phosphate.
The
final
effector
is
probably
the
permeability
transition
pore
produces
protection
by
preventing
formation.
Many
investigators
have
worked
to
produce
a
roadmap
this
with
hope
it
would
reveal
where
one
could
intervene
therapeutically
protect
patients
acute
infarction
whose
hearts
being
reperfused.
However,
attempts
date
show
efficacy
such
an
intervention
in
large
clinical
trials
been
unsuccessful.
Reasons
for
inability
translate
successes
experimental
laboratory
arena
evaluated
review.
It
suggested
all
coronary
syndromes
currently
presenting
hospital
treated
platelet
P2Y12
receptor
antagonists,
current
standard
care,
indeed
already
benefiting
conditioning
outlined
earlier.
If
proves
be
case,
then
future
further
will
rely
which
different
mechanism.
British Journal of Pharmacology,
Journal Year:
2014,
Volume and Issue:
171(13), P. 3196 - 3211
Published: Feb. 26, 2014
The
histone
acetyltransferase
MOF
is
a
member
of
the
MYST
family.
In
mammals,
plays
critical
roles
by
acetylating
H4
at
K16
and
non-histone
substrates
such
as
p53.
Here
we
have
investigated
role
in
human
lung
cancer
possible
new
hMOF.Samples
non-small
cell
(NSCLC)
were
used
to
correlate
with
clinicopathological
parameters
NF-E2-related
factor
2
(Nrf2)
downstream
genes.
293T-cells
study
interactions
between
Nrf2,
acetylation
Nrf2
MOF.
Mouse
embryonic
fibroblast
A549
cells
utilized
assess
involvement
antioxidative
anti-drug
responses.
analysis
response
vitro
vivo.hMOF
was
overexpressed
NSCLC
tissues
associated
large
tumour
size,
advanced
disease
stage
metastasis,
poor
prognosis.
hMOF
levels
positively
correlated
Nrf2-downstream
MOF/hMOF
physically
interacted
acetylated
Lys(588)
.
MOF-mediated
increased
nuclear
retention
transcription
its
Importantly,
essential
for
anti-oxidative
responses
regulated
growth
drug
resistance
vivo
an
Nrf2-dependent
manner.hMOF
predictor
survival.
hMOF-mediated
are
may
provide
therapeutic
target
treatment
NSCLC.
Current Topics in Medicinal Chemistry,
Journal Year:
2019,
Volume and Issue:
20(1), P. 37 - 56
Published: Dec. 30, 2019
Type
2
diabetes
mellitus
is
a
complex
progressive
endocrine
disease
characterized
by
hyperglycemia
and
life-threatening
complications.
It
the
most
common
disorder
of
pancreatic
cell
function
that
causes
insulin
deficiency.
Sulfonylurea
class
oral
hypoglycemic
drugs.
Over
past
half
century,
these
drugs,
together
with
subsequent
non-sulfonylureas
(glinides),
have
been
main
drugs
for
secretion.Through
in-depth
study,
medical
profession
considers
it
as
an
important
drug
improving
blood
sugar
control.The
mechanism,
characteristics,
efficacy
side
effects
sulfonylureas
glinides
were
reviewed
in
detail.Sulfonylureas
not
only
stimulated
release
from
cells,
but
also
had
many
extrapanular
effect,
such
reducing
clearance
rate
liver,
secretion
glucagon,
enhancing
sensitivity
peripheral
tissues
to
type
mellitus.Sulfonylureas
are
effective
first-line
treatment
mellitus.
Although
they
risk
hypoglycemia,
weight
gain
cardiovascular
disease,
their
clinical
practicability
safety
can
be
guaranteed
long
reasonably
used.
British Journal of Pharmacology,
Journal Year:
2014,
Volume and Issue:
171(20), P. 4556 - 4574
Published: Feb. 17, 2014
Anxiety
disorders
pose
one
of
the
biggest
threats
to
mental
health
in
world,
and
they
predominantly
emerge
early
life.
However,
research
anxiety
fear‐related
memories
during
development
has
been
largely
neglected,
existing
treatments
have
developed
based
on
adult
models
anxiety.
The
present
review
describes
animal
across
what
is
currently
known
their
pharmacology.
To
summarize,
underlying
mechanisms
intrinsic
‘unlearned’
fear
are
poorly
understood,
especially
beyond
period
infancy.
Models
using
‘learned’
reveal
that
through
development,
rats
exhibit
a
stress
hyporesponsive
before
postnatal
day
10,
where
paradoxically
form
odour‐shock
preferences,
then
switch
more
adult‐like
conditioned
responses.
Juvenile
appear
forget
these
aversive
associations
easily,
as
observed
with
phenomenon
infantile
amnesia.
also
undergo
robust
extinction,
until
adolescence
display
increased
resistance
extinction.
Maturation
brain
structures,
such
amygdala,
prefrontal
cortex
hippocampus,
along
different
temporal
recruitment
involvement
various
neurotransmitter
systems
(including
NMDA
,
GABA
corticosterone
opioids)
responsible
for
developmental
changes.
Taken
together,
studies
described
this
highlight
there
be
overcoming
adverse
life
experience.
We
need
understand
fundamental
pharmacological
processes
order
take
advantage
treatment
disorders.
Linked
Articles
This
article
part
themed
section
Animal
Psychiatry
Research.
view
other
articles
visit
http://dx.doi.org/10.1111/bph.2014.171.issue-20
Frontiers in Cardiovascular Medicine,
Journal Year:
2020,
Volume and Issue:
6
Published: Jan. 8, 2020
Three
cardiovascular
outcome
trials
of
sodium
glucose
cotransporter
2
(SGLT2)
inhibitors,
including
the
EMPA-REG
OUTCOME
trial,
CANVAS
Program,
and
DECLARE
TIMI
58
revealed
that
SGLT2
inhibitors
were
superior
to
a
matching
placebo
in
reducing
events,
mortality
hospitalization
for
heart
failure,
patients
with
type
diabetes.
However,
detailed
mechanism
underlying
beneficial
effects
exert
on
diseases
remains
be
elucidated.
We
herein
review
latest
findings
salutary
mechanisms
cardiomyocytes,
especially
focusing
their
mitochondrial
function-mediated
effects.
The
administration
leads
elevation
plasma
levels
ketone
bodies,
which
are
an
efficient
energy
source
failing
heart,
by
promoting
oxidation
coenzyme
Q
couple
enhancing
free
cytosolic
ATP
hydrolysis.
also
promote
metabolism-mediated
cardioprotective
These
compounds
could
reduce
intracellular
overload
improve
energetics
oxidative
defense
through
binding
NHE
and/or
SMIT1.
Furthermore,
modulate
dynamics
regulating
fusion
fission
mitochondria.
Together
ongoing
large-scale
clinical
evaluate
efficacy
intensive
investigations
regarding
restoration
cases
failure
would
lead
establishment
these
drugs
as
potent
anti-heart
drugs.
British Journal of Pharmacology,
Journal Year:
2015,
Volume and Issue:
173(13), P. 2069 - 2079
Published: June 9, 2015
Endocannabinoids
and
their
receptors
play
a
modulatory
role
in
the
control
of
dopamine
transmission
basal
ganglia.
However,
this
influence
is
generally
indirect
exerted
through
modulation
GABA
glutamate
inputs
received
by
nigrostriatal
dopaminergic
neurons,
which
lack
cannabinoid
CB
1
although
they
may
produce
endocannabinoids.
Additional
evidence
suggests
that
2
be
located
certain
eicosanoid‐related
cannabinoids
directly
activate
TRPV
receptors,
have
been
found
thus
allowing
both
cases
direct
regulation
specific
cannabinoids.
In
addition,
form
heteromers
with
provide
another
pathway
to
interactions
between
systems,
case
at
postsynaptic
level.
Through
these
mechanisms
or
involving
interact
ganglia
likely
important
effects
on
dopamine‐related
functions
structures
(i.e.
movement)
and,
particularly,
different
pathologies
affecting
processes,
particular,
Parkinson's
disease,
but
also
dyskinesia,
dystonia
other
pathological
conditions.
The
present
review
will
address
current
literature
supporting
cannabinoid–dopamine
ganglia,
emphasis
aspects
dealing
physiopathological
consequences
interactions.
Linked
Articles
This
article
part
themed
section
Updating
Neuropathology
Neuropharmacology
Monoaminergic
Systems.
To
view
articles
visit
http://onlinelibrary.wiley.com/doi/10.1111/bph.v173.13/issuetoc
British Journal of Pharmacology,
Journal Year:
2014,
Volume and Issue:
171(11), P. 2814 - 2826
Published: Jan. 28, 2014
Background
and
Purpose
Stress
exposure
produces
excitotoxicity
neuroinflammation,
contributing
to
the
cellular
damage
observed
in
stress‐related
neuropathologies.
The
endocannabinoids
provide
a
homeostatic
system,
present
stress‐responsive
neural
circuits.
Here,
we
have
assessed
possible
regulatory
role
of
cannabinoid
CB
2
receptors
stress‐induced
neuroinflammation.
Experimental
Approach
We
used
wild
type
(
WT
),
transgenic
overexpressing
2x
P
)
receptor
knockout
2‐
KO
mice
exposed
immobilization
acoustic
stress
(2
h·day
−1
for
4
days).
agonist
JWH
‐133
was
administered
daily
mg·kg
,
i.p.)
animals.
Glutamate
uptake
measured
synaptosomes
from
frontal
cortex;
Western
blots
RT‐PCR
were
measure
proinflammatory
cytokines,
enzymes
mediators
homogenates
cortex.
Key
Results
Increased
plasma
corticosterone
induced
by
not
modified
manipulating
receptors.
treatment
or
overexpression
increased
control
levels
glutamate
uptake,
which
reduced
back
levels.
prevented
increase
cytokines
TNF
‐α
CCL2),
NF‐κB
NOS
‐2
COX
consequent
oxidative
nitrosative
(lipid
peroxidation).
exhibited
anti‐inflammatory
neuroprotective
actions
similar
those
pretreated
Conversely,
lack
mice)
exacerbated
neuroinflammatory
responses
confirmed
that
effects
mediated
through
Conclusions
Implications
Pharmacological
manipulation
is
potential
therapeutic
strategy
pathologies
with
component,
such
as
depression.
British Journal of Pharmacology,
Journal Year:
2014,
Volume and Issue:
171(13), P. 3255 - 3267
Published: March 6, 2014
Background
and
Purpose
The
testing
of
anticancer
compounds
in
vitro
is
usually
performed
hyperglycaemic
cell
cultures,
although
many
tumours
their
vivo
microenvironments
are
hypoglycaemic.
Here,
we
have
assessed,
cultures
tumour
cells,
the
effects
reduced
glucose
levels
on
resistance
to
drugs
investigated
underlying
cellular
mechanisms.
Experimental
Approach
PIK3CA
mutant
(
AGS
,
HGC
27),
wild‐type
MKN
45,
NUGC
4)
gastric
cancer
cells
were
cultured
high‐glucose
HG
25
mM)
or
low‐glucose
LG
5
media
tested
for
sensitivity
two
cytotoxic
compounds,
5‐fluorouracil
(5‐
FU
)
carboplatin,
PI
3
K
/
mTOR
inhibitor,
103
Ku
‐0063794.
Key
Results
All
had
increased
5‐
carboplatin
when
compared
with
conditions
despite
having
similar
growth
cycle
characteristics.
On
treatment
‐0063794,
only
displayed
conditions.
selectively
p‐
S
6,
p‐4
EBP
1,
GLUT
1
lactate
production,
reactive
oxygen
species,
consistent
glycolysis.
Combination
analysis
indicated
‐0063794
synergistic
only.
Synergism
was
accompanied
by
signalling
autophagy.
Conclusions
Implications
Hypoglycaemia
agents,
especially
a
high
dependence
Dual
inhibition
pathway
may
be
able
attenuate
such
hypoglycaemia‐associated
resistance.